Vera Therapeutics VERA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$121.03M-32.9% | -$91.1M-13.5% | -$80.29M-4.9% | -$76.53M-48.0% | -$51.69M-19.0% | ||
| $140K+3.7% | $135K+4.7% | $129K+8.4% | $119K+40.0% | $85K+54.5% | ||
| $13.21M+20.5% | $10.97M+12.5% | $9.75M+2.9% | $9.47M+22.3% | $7.74M+24.6% | ||
| -$7.97M-320% | $3.63M-24.4% | $4.79M+23.1% | $3.9M+144% | $1.6M— | ||
| -$437K-106% | $7.21M+84.1% | $3.92M-51.7% | $8.1M+269% | -$4.78M— | ||
| $5.14M+1,283% | $372K— | —— | —— | $5.88M+1,285% | ||
| $116K+2.7% | $113K-74.0% | $435K-2.0% | $444K-2.8% | $457K-16.6% | ||
| -$182K-82.0% | -$100K+80.8% | -$520K-10.9% | -$469K-19.0% | -$394K+25.5% | ||
| $0+100% | -$1K— | —— | -$141K-729% | -$17K-88.9% | ||
| -$106.5M-52.2% | -$69.99M-13.1% | -$61.91M-13.0% | -$54.8M-0.7% | -$54.41M-38.9% | ||
| $23K-77.5% | $102K-23.3% | $133K-36.1% | $208K+11.2% | $187K-71.0% | ||
| -$137.82M-271% | $80.66M+15.6% | $69.76M+144% | $28.54M+86.4% | $15.32M+107% | ||
| —— | $0— | —— | —— | —— | ||
| $3.94M-5.9% | $4.19M+425% | $797K+71.8% | $464K-69.7% | $1.53M-33.7% | ||
| $3.94M-98.6% | $286.28M+35,820% | $797K-96.1% | $20.29M+1,223% | $1.53M-99.5% | ||
| -$240.37M-181% | $296.95M+3,332% | $8.65M+245% | -$5.97M+84.1% | -$37.56M-157% | ||
| $1.63M-4.9% | $1.72M-2.8% | $1.77M+6.6% | $1.66M+4.8% | $1.58M-4.9% | ||
| -$843K— | —— | —— | —— | -$2.53M-22.5% | ||
| $639K— | —— | —— | —— | $221K+1.8% | ||
| -$182K-82.0% | -$100K+80.8% | -$520K-10.9% | -$469K-19.0% | -$394K+25.5% | ||
| $0+100% | -$1K— | —— | -$141K-729% | -$17K-88.9% | ||
| $5.14M+1,283% | $372K— | —— | —— | $5.88M+1,285% | ||
| $116K+2.7% | $113K-74.0% | $435K-2.0% | $444K-2.8% | $457K-16.6% | ||
| $15M— | —— | —— | —— | $750K— | ||
| $150K— | —— | —— | —— | $0— | ||
| $15M— | —— | —— | —— | $750K— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $3.94M-5.9% | $4.19M+425% | $797K+71.8% | $464K-69.7% | $1.53M-33.7% | ||
| $188K— | —— | —— | —— | $634K— | ||
| -$182K-82.0% | -$100K+80.8% | -$520K-10.9% | -$469K-19.0% | -$394K+25.5% | ||
| —— | $63K0.0% | $63K0.0% | $63K0.0% | $63K— | ||
| $193K— | —— | —— | —— | $0— | ||
| -$106.52M-52.0% | -$70.1M-13.0% | -$62.04M-12.8% | -$55.01M-0.8% | -$54.59M-37.1% | ||
| -$106.52M-52.0% | -$70.1M-13.0% | -$62.04M-12.8% | -$55.01M-0.8% | -$54.59M-37.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Vera Therapeutics's cash flow data come from?
- Every line is extracted from Vera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.